Briefing Note: Remdesivir approach for Q4 2023-24

Back to search
Title:
Remdesivir approach for Q4 2023-24
Additional Information:
-
Received:
Jan 25, 2024
Organization:
Public Health Agency of Canada
Sector:
Infectious Disease and Vaccination Programs Branch
Addressee:
Deputy head (including a person appointed to a position of an equivalent rank)
Action Required:
For Decision
Reference Number:
24-100128-211